Yousif Capital Management LLC Trims Stake in Privia Health Group, Inc. (NASDAQ:PRVA)

Yousif Capital Management LLC lessened its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 1.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 39,714 shares of the company’s stock after selling 679 shares during the quarter. Yousif Capital Management LLC’s holdings in Privia Health Group were worth $776,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Park Avenue Securities LLC raised its stake in shares of Privia Health Group by 3.8% during the fourth quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock worth $287,000 after purchasing an additional 532 shares during the last quarter. Sequoia Financial Advisors LLC increased its stake in Privia Health Group by 2.3% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 26,246 shares of the company’s stock valued at $478,000 after buying an additional 583 shares during the period. GAMMA Investing LLC raised its position in Privia Health Group by 98.7% during the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock worth $31,000 after buying an additional 845 shares during the last quarter. KBC Group NV lifted its stake in shares of Privia Health Group by 34.6% in the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock worth $62,000 after acquiring an additional 871 shares during the period. Finally, Trust Point Inc. boosted its holdings in shares of Privia Health Group by 3.5% in the third quarter. Trust Point Inc. now owns 41,130 shares of the company’s stock valued at $749,000 after acquiring an additional 1,386 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Analysts Set New Price Targets

PRVA has been the subject of several analyst reports. Stephens reissued an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a report on Thursday, January 2nd. Macquarie started coverage on Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target for the company. Barclays lifted their price target on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, November 8th. JPMorgan Chase & Co. increased their price objective on Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research report on Friday, November 29th. Finally, JMP Securities restated a “market outperform” rating and set a $26.00 target price on shares of Privia Health Group in a research report on Friday. Two research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, Privia Health Group has an average rating of “Buy” and an average price target of $24.94.

Privia Health Group Stock Up 1.5 %

NASDAQ PRVA opened at $25.24 on Friday. Privia Health Group, Inc. has a fifty-two week low of $15.92 and a fifty-two week high of $25.49. The business has a fifty day moving average of $21.62 and a 200-day moving average of $20.23. The stock has a market cap of $3.03 billion, a price-to-earnings ratio of 252.43, a price-to-earnings-growth ratio of 3.07 and a beta of 0.87.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.